TY - JOUR
T1 - Cost-effectiveness of robotic compared with laparoscopic rectal resection. Results from the Spanish prospective national trial ROBOCOSTES
AU - Guerrero, Maria-Alejandra
AU - Pellino, Gianluca
AU - Gimeno, Marta
AU - Alonso-Marsol, Sandra
AU - Podda, Mauro
AU - Toledano, Miguel
AU - Núñez-Alfonsel, Javier
AU - Selvaggi, Lucio
AU - Acosta Mérida, M.A.
AU - Bellido-Luque, Juan
AU - Ielpo, Benedetto
AU - Sánchez Guillén, Luis
AU - Diaz Lara, Carlos Javier
AU - Noguera Aguilar, José Francisco
AU - García Orozco, Julián
AU - González Bermúdez, Manuel
AU - Castro Boix, Sandra
AU - Gantxegi, Amaia
AU - Espin-Basany, Eloy
AU - Kraft, Miquel
AU - Pando, Elizabeth
AU - Fernandes, Nair
AU - López Cano, Manuel
AU - Fernández Luengas, David
AU - Zárate Gómez, Jorge
AU - Álvarez de Sierra Hernández, Pedro
AU - Sánchez-Santos, Raquel
AU - Cano-Valderrama, O.
AU - Nogueira Sixto, Manuel
AU - Álvarez Garrido, Nicolás
AU - Iglesias Trigo, Marta
AU - Pujadas, Marcel
AU - Codony Bassols, Clara
AU - Ortega-Torrecilla, Nuria
AU - Planellas Giné, Pere
AU - López-Ben, Santiago
AU - Vicente, Emilio
AU - Caruso, Ricardo
AU - Ferri, Valentina
AU - Álvarez García, Helena
AU - Abascal Amo, Aro
AU - Etreros Alonso, Javier
AU - Martinez Cortijo, Sagrario
AU - Alberto Lasaia, Manuel
AU - Linacero, Santiago
AU - Morante, Ana Pilar
AU - Martín Del Olmo, Juan Carlos
AU - Álvarez Gallego, Mario
AU - Guevara, Jenny
AU - Gutiérrez Iscar, Eduardo
AU - Olivares Pizarro, Sergio Pedro
AU - Ríos Blanco, Raquel
AU - Josa Martínez, Benito Miguel
AU - Pacheco Sánchez, David
AU - Simó, Vicente
AU - Sánchez González, Javier
AU - Trébol, Jacobo
AU - Tresierra Carranza, Luis Alfredo
AU - Alías Jiménez, David
AU - Díaz García, Gustavo
AU - Guadalajara, Héctor
AU - León Arellano, Miguel
AU - Jorba, Rosa
AU - Babiloni Simón, Sonia
AU - Díez Del Val, Ismael
AU - Castro Vázquez, Joseba
AU - Ortega, Nuria
AU - Pastor, Carlos
AU - Arredondo Chaves, Jorge
PY - 2025
Y1 - 2025
N2 - Objective: The costs related to robotic surgery are known to be greater than those associated with laparoscopy. However, the potential for better outcomes of the former could lead to a cost-effectiveness advantage. The aim of this study is therefore to highlight the difference in cost-effectiveness between robotic and laparoscopic rectal resection. Methods: This is an observational, multicenter, national prospective study (ROBOCOSTES). From 2022, for 1 year, all consecutive patients undergoing minimally invasive rectal resection were included. Quality-adjusted life year and cost data were prospectively collected. The primary aim was to assess the cost-effectiveness of robotic rectal resection and laparoscopic rectal resection. Secondary aims included clinical outcomes and quality of life. Results: Overall, 182 patients underwent rectal resection (152 anterior and 30 abdominoperineal excisions) at 14 centers, of whom 95 received robotic rectal resection and 87 laparoscopic rectal resection. Robotic rectal resection was associated with lesser blood loss (58.55 ± 51.68 vs 131.68 ± 191.92, P <.001), lower pain score at day 1 (-1.04 visual analog scale, P <.001) and day 7 (-0.81, P <.001) after surgery, and with fewer hospital readmissions (2.1% vs 15%, P =.005) compared with laparoscopic rectal resection. The overall costs of robotic rectal resection (including hospitalization) were 919.66 euros greater compared with laparoscopic rectal resection, but quality-adjusted life years in the robotic rectal resection group were better than laparoscopic approaches to rectal resection both at 30-day (0.8914 vs 0.8139) and 90-day (0.9573 vs 0.8740) follow-up. At a willingness-to-pay threshold of 20,000 and 30,000 euros, there was an 84.38% and 89.36% probability that robotic rectal resection was more cost-effective than laparoscopic rectal resection. Conclusion: This study showed that robotic rectal resection, even if associated with greater direct costs in the short term, outperforms laparoscopic rectal resection in terms of quality-adjusted life years and should therefore be preferred where available.
AB - Objective: The costs related to robotic surgery are known to be greater than those associated with laparoscopy. However, the potential for better outcomes of the former could lead to a cost-effectiveness advantage. The aim of this study is therefore to highlight the difference in cost-effectiveness between robotic and laparoscopic rectal resection. Methods: This is an observational, multicenter, national prospective study (ROBOCOSTES). From 2022, for 1 year, all consecutive patients undergoing minimally invasive rectal resection were included. Quality-adjusted life year and cost data were prospectively collected. The primary aim was to assess the cost-effectiveness of robotic rectal resection and laparoscopic rectal resection. Secondary aims included clinical outcomes and quality of life. Results: Overall, 182 patients underwent rectal resection (152 anterior and 30 abdominoperineal excisions) at 14 centers, of whom 95 received robotic rectal resection and 87 laparoscopic rectal resection. Robotic rectal resection was associated with lesser blood loss (58.55 ± 51.68 vs 131.68 ± 191.92, P <.001), lower pain score at day 1 (-1.04 visual analog scale, P <.001) and day 7 (-0.81, P <.001) after surgery, and with fewer hospital readmissions (2.1% vs 15%, P =.005) compared with laparoscopic rectal resection. The overall costs of robotic rectal resection (including hospitalization) were 919.66 euros greater compared with laparoscopic rectal resection, but quality-adjusted life years in the robotic rectal resection group were better than laparoscopic approaches to rectal resection both at 30-day (0.8914 vs 0.8139) and 90-day (0.9573 vs 0.8740) follow-up. At a willingness-to-pay threshold of 20,000 and 30,000 euros, there was an 84.38% and 89.36% probability that robotic rectal resection was more cost-effective than laparoscopic rectal resection. Conclusion: This study showed that robotic rectal resection, even if associated with greater direct costs in the short term, outperforms laparoscopic rectal resection in terms of quality-adjusted life years and should therefore be preferred where available.
KW - Rectal cancer
KW - Laparoscopy
KW - Robotic
KW - Robotic assisted
KW - Cost effectiveness
U2 - 10.1016/j.surg.2024.109134
DO - 10.1016/j.surg.2024.109134
M3 - Article
C2 - 39879899
SN - 0039-6060
VL - 180
JO - Surgery
JF - Surgery
ER -